Phenylethylamine-like properties of baclofen.
Baclofen therapy resulted in improvement of dyskinesias only in patients with trunkal tardive dyskinesia. However, the appearance of undesirable side effects did not warrant continuation of treatment with this drug. Baclofen did not have any therapeutic effect in schizophrenia and moreover a trend towards a worsening of the psychiatric conditions with irritability, assaultiveness and prominent auditory hallucinations was observed. The effects of baclofen on tardive dyskinesia and schizophrenia can be explained in terms of its phenylethylamine-like properties.
D000328:Adult; D000368:Aged; D001418:Baclofen / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D010627:Phenethylamines / Q000494:pharmacology*; D012559:Schizophrenia / Q000188:drug therapy*
D010627:Phenethylamines; D001418:Baclofen